Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy (Q34513788)

2 August 2017

title

Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy (English)

1 reference

2 August 2017

0 references

van Geel BM

1

1 reference

2 August 2017

Bezman L

2

1 reference

2 August 2017

Loes DJ

3

1 reference

2 August 2017

Moser HW

4

1 reference

2 August 2017

Raymond GV

5

1 reference

2 August 2017

publication date

1 February 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

49

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

186-194

1 reference

Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Therapy of X-linked adrenoleukodystrophy: prognosis based upon age and MRI abnormality and plans for placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

The clinical meaning of Rankin 'handicap' grades after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Lorenzo's oil--hope and disappointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Nerve conduction studies in adrenomyeloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Adrenoleukodystrophy: phenotypic variability and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

X-linked adrenoleukodystrophy: genes, mutations, and phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%2820010201%2949%3A2%3C186%3A%3AAID-ANA38%3E3.0.CO%3B2-R

10.1002/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference